 |
Autologous dendritic cells pulsed with autologous antigens from primay malignant brain tumor cells |
|---|---|
| Trade Name | Dcvax-Brain |
| Orphan Indication | Primary brain malignant cancer |
| USA Market Approval | USA |
| USA Designation Date | 2002-11-29 00:00:00 |
| Sponsor | Northwest Biotherapeutics, Inc.;22322 20th Avenue SE, Suite 150;Bothell, Washington, 98021 |
